Verified Nov 2026
Other
·

Foster City, California
·
Since 2018
Mirum Pharmaceuticals is a biopharmaceutical company headquartered in Foster City, California, founded in 2018. With 200–500 employees and estimated revenue of $500M–$1B, the company develops treatments for rare liver and genetic diseases. Its approved medications include LIVMARLI for Alagille syndrome, CHOLBAM for bile-acid synthesis disorders, and CTEXLI for cerebrotendinous xanthomatosis, with a clinical pipeline targeting conditions including primary sclerosing cholangitis and Fragile X syndrome.
Mirum Pharmaceuticals, Inc. at a glance
Revenue
$500M-1B
Est. band
Employees
200-500
Founded
2018
Headquarters
Foster City, California
Industries
Automotive
Electric Vehicles
Medical
Overview
Mirum Pharmaceuticals is a biopharmaceutical company headquartered in Foster City, California, founded in 2018. With 200–500 employees and estimated revenue of $500M–$1B, the company develops treatments for rare liver and genetic diseases. Its approved medications include LIVMARLI for Alagille syndrome, CHOLBAM for bile-acid synthesis disorders, and CTEXLI for cerebrotendinous xanthomatosis, with a clinical pipeline targeting conditions including primary sclerosing cholangitis and Fragile X syndrome.
At a glance
Attribute | Detail |
|---|---|
Founded | 2018 |
Headquarters | Foster City, California |
Employees | 200-500 |
Revenue | $500M-1B (estimated) |
What Mirum Pharmaceuticals, Inc. makes
The company markets three FDA-approved medications for rare metabolic and genetic liver disorders and maintains a clinical-stage pipeline with several investigational medicines in development.
Latest developments
2026-11-03 — Mirum Pharmaceuticals, Inc. - Mirum Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update (mirumpharma.com)
2026-05-12 — Mirum Pharmaceuticals, Inc. - Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering (mirumpharma.com)
2026-01-26 — Mirum Pharmaceuticals, Inc. - Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease (mirumpharma.com)
2025-12-08 — Mirum Pharmaceuticals, Inc. - Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease (mirumpharma.com)
2025-12-08 — Mirum to buy Bluejay for up to $820 million in bet on liver-disease drug | Reuters (reuters.com)
Company details
Mirum operates globally with team members in North America and Europe, serving patients with rare and life-threatening diseases through direct engagement with healthcare providers and clinical trial participation. Mirum Pharmaceuticals, Inc. was founded in 2018, has an estimated 200-500 employees, and is headquartered in Foster City, California.
Frequently asked questions
What does Mirum Pharmaceuticals, Inc. do?
Mirum Pharmaceuticals is a biopharmaceutical company headquartered in Foster City, California, founded in 2018. With 200–500 employees and estimated revenue of $500M–$1B, the company develops treatments for rare liver and genetic diseases. Its approved medications include LIVMARLI for Alagille syndrome, CHOLBAM for bile-acid synthesis disorders, and CTEXLI for cerebrotendinous xanthomatosis, with a clinical pipeline targeting conditions including primary sclerosing cholangitis and Fragile X syndrome.
Where is Mirum Pharmaceuticals, Inc. headquartered?
Mirum Pharmaceuticals, Inc. is headquartered in Foster City, California (950 Tower Lane, Foster City, California, 94404).
When was Mirum Pharmaceuticals, Inc. founded?
Mirum Pharmaceuticals, Inc. was founded in 2018.
How big is Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. has an estimated 200-500 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
